All Stories

  1. Dopaminergic changes in the subgenual cingulate cortex in dementia with lewy bodies associates with presence of depression

    Article • Translational Psychiatry, March 2025, Springer Science + Business Media

    Dr Christopher M Morris

  2. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders

    Article • Acta Neuropathologica, September 2021, Springer Science + Business Media

    Dr Christopher M Morris

  3. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies

    Article • Biomolecules, May 2021, MDPI AG

    Dr Christopher M Morris

  4. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

    Article • Nature Genetics, February 2021, Springer Science + Business Media

    Dr Christopher M Morris

  5. Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein

    Article • Neurobiology of Disease, February 2021, Elsevier

    Dr Christopher M Morris

  6. C9orf72 , age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

    Article • Neurology, December 2020, Wolters Kluwer Health

    Dr Christopher M Morris

  7. Prospective longitudinal evaluation of cytokines in mild cognitive impairment due to AD and Lewy body disease

    Article • International Journal of Geriatric Psychiatry, July 2020, Wiley

    Dr Christopher M Morris

  8. Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress

    Article • Neuropathology and Applied Neurobiology, June 2020, Wiley

    Dr Christopher M Morris

  9. Label‐Free Nanoimaging of Neuromelanin in the Brain by Soft X‐ray Spectromicroscopy

    Article • Angewandte Chemie, May 2020, Wiley

    Dr Christopher M Morris

  10. Label‐Free Nanoimaging of Neuromelanin in the Brain by Soft X‐ray Spectromicroscopy

    Article • Angewandte Chemie, May 2020, Wiley

    Dr Christopher M Morris

  11. Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases

    Article • Brain Pathology, May 2020, Wiley

    Dr Christopher M Morris

  12. Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia

    Article • Brain, November 2019, Oxford University Press (OUP)

    Dr Christopher M Morris

  13. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice

    Article • Neuroscience Letters, October 2019, Elsevier

    Dr Christopher M Morris

  14. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy

    Article • Acta Neuropathologica, July 2019, Springer Science + Business Media

    Shuo-Chien Ling, Dr Christopher M Morris

  15. Assessment of APOE in atypical parkinsonism syndromes

    Article • Neurobiology of Disease, July 2019, Elsevier

    Dr Christopher M Morris

  16. MAPT p.V363I mutation

    Article • Neurology Genetics, June 2019, Wolters Kluwer Health

    Dr Christopher M Morris

  17. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

    Article • Acta Neuropathologica, May 2019, Springer Science + Business Media

    Dr Christopher M Morris

  18. Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign

    Article • Journal of Neuropathology & Experimental Neurology, May 2019, Oxford University Press (OUP)

    Dr Christopher M Morris

  19. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease

    Article • International Journal of Geriatric Psychiatry, May 2019, Wiley

    Dr Christopher M Morris

  20. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders

    Article • Brain Pathology, January 2019, Wiley

    Dr Christopher M Morris

  21. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease

    Article • Neuropathology and Applied Neurobiology, December 2018, Wiley

    Dr Christopher M Morris

  22. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

    Article • Nature Medicine, December 2018, Springer Science + Business Media

    Dr Christopher M Morris

  23. LRP10 in α-synucleinopathies

    Article • The Lancet Neurology, December 2018, Elsevier

    Dr Christopher M Morris

  24. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease

    Article • Alzheimer s & Dementia, December 2018, Elsevier

    Dr Christopher M Morris

  25. High prevalence of focal and multi-focal somatic genetic variants in the human brain

    Article • Nature Communications, October 2018, Springer Science + Business Media

    Dr Christopher M Morris

  26. Frequency and signature of somatic variants in 1461 human brain exomes

    Article • Genetics in Medicine, September 2018, Springer Science + Business Media

    Dr Christopher M Morris

  27. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target

    Article • Brain, August 2018, Oxford University Press (OUP)

    Dr Christopher M Morris

  28. The impact of stapling technique and surgeon specialism on anastomotic failure after right-sided colorectal resection: an international multicentre, prospective audit

    Article • Colorectal Disease, July 2018, Wiley

    Dr Christopher M Morris, Dale Vimalachandran, Dr Dejan Ignjatovic

  29. CXCR4 involvement in neurodegenerative diseases

    Article • Translational Psychiatry, April 2018, Springer Science + Business Media

    Dr Christopher M Morris

  30. Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease

    Article • npj Parkinson s Disease, March 2018, Springer Science + Business Media

    Dr Christopher M Morris

  31. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies

    Article • Movement Disorders, March 2018, Wiley

    Dr Christopher M Morris

  32. Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 2018, BMJ

    Dr Christopher M Morris

  33. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

    Article • PLoS Medicine, January 2018, PLOS

    Dr Christopher M Morris

  34. Gene expression analysis reveals chronic low level exposure to the pesticide diazinon affects psychological disorders gene sets in the adult rat

    Article • Toxicology, January 2018, Elsevier

    Dr Christopher M Morris

  35. Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2017, BMJ

    Dr Christopher M Morris

  36. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease

    Article • Annals of Neurology, December 2017, Wiley

    Dr Christopher M Morris

  37. Regional levels of physiological α-synuclein are directly associated with Lewy body pathology

    Article • Acta Neuropathologica, November 2017, Springer Science + Business Media

    Dr Christopher M Morris

  38. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection An international audit by ESCP and S-ECCO

    Article • Colorectal Disease, September 2017, Wiley

    Alaa El-Hussuna, Mr Ian Daniels, Dr Christopher M Morris, Dale Vimalachandran, Dr Dejan Ignjatovic

  39. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson’s disease

    Article • BMC Neuroscience, June 2017, Springer Science + Business Media

    Dr Christopher M Morris

  40. Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies

    Article • American Journal of Geriatric Psychiatry, June 2017, Elsevier

    Dr Christopher M Morris

  41. The relationship between method of anastomosis and anastomotic failure after right hemicolectomy and ileo-caecal resection: an international snapshot audit

    Article • Colorectal Disease, March 2017, Wiley

    Mr Neil J Smart, Mr Ian Daniels, Dr Christopher M Morris, Dale Vimalachandran, Dr Dejan Ignjatovic

  42. Trichloroethylene-induced formic aciduria in the male C57 Bl/6 mouse

    Article • Toxicology, March 2017, Elsevier

    Dr Christopher M Morris

  43. Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

    Article • Acta Neuropathologica Communications, February 2017, Springer Science + Business Media

    Dr Christopher M Morris

  44. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

    Article • Acta Neuropathologica Communications, February 2017, Springer Science + Business Media

    Dr Christopher M Morris

  45. Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies

    Article • Movement Disorders, January 2017, Wiley

    Dr Christopher M Morris

  46. Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration

    Article • Parkinson s Disease, January 2017, Hindawi Publishing Corporation

    Dr Christopher M Morris

  47. Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource

    Article • Genome Research, December 2016, Cold Spring Harbor Laboratory Press

    Dr Christopher M Morris

  48. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2016, BMJ

    Dr Christopher M Morris

  49. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK

    Article • Acta Neuropathologica, September 2016, Springer Science + Business Media

    Dr Christopher M Morris

  50. Anatomic Connections of the Subgenual Cingulate Region

    Article • Neurosurgery, September 2016, Oxford University Press (OUP)

    Dr Christopher M Morris

  51. Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

    Article • Acta Neuropathologica Communications, June 2016, Springer Science + Business Media

    Dr Christopher M Morris

  52. Telomerase Activity is Downregulated Early During Human Brain Development

    Article • Genes, June 2016, MDPI AG

    Dr Christopher M Morris

  53. Development of passive CLARITY and immunofluorescent labelling of multiple proteins in human cerebellum: understanding mechanisms of neurodegeneration in mitochondrial disease

    Article • Scientific Reports, May 2016, Springer Science + Business Media

    Dr Christopher M Morris

  54. A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat

    Article • PLOS One, February 2016, PLOS

    Dr Christopher M Morris

  55. Mechanism for the acute effects of organophosphate pesticides on the adult 5-HT system

    Article • Chemico-Biological Interactions, February 2016, Elsevier

    Dr Christopher M Morris

  56. Exome sequencing in dementia with Lewy bodies

    Article • Translational Psychiatry, February 2016, Springer Science + Business Media

    Dr Christopher M Morris

  57. Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons

    Article • Annals of Neurology, January 2016, Wiley

    Dr Christopher M Morris

  58. Low-level repeated exposure to diazinon and chlorpyrifos decrease anxiety-like behaviour in adult male rats as assessed by marble burying behaviour

    Article • NeuroToxicology, September 2015, Elsevier

    Dr Christopher M Morris

  59. Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2015, Springer Science + Business Media

    Dr Christopher M Morris

  60. Erratum to: Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria

    Article • Archives of Toxicology, June 2015, Springer Science + Business Media

    Dr Christopher M Morris

  61. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies

    Article • Neuropathology and Applied Neurobiology, June 2015, Wiley

    Dr Christopher M Morris

  62. Neural Differentiation Modulates the Vertebrate Brain Specific Splicing Program

    Article • PLOS One, May 2015, PLOS

    Dr Christopher M Morris

  63. Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies

    Article • Molecular Neurodegeneration, March 2015, Springer Science + Business Media

    Dr Christopher M Morris

  64. Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria

    Article • Archives of Toxicology, February 2015, Springer Science + Business Media

    Dr Christopher M Morris

  65. Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes

    Article • Emergency Medicine Journal, November 2014, BMJ

    Dr Christopher M Morris

  66. Frontotemporal dementia and its subtypes: a genome-wide association study

    Article • The Lancet Neurology, July 2014, Elsevier

    Dr Christopher M Morris, Jordi Clarimon

  67. Intralobar fibres of the occipital lobe: A post mortem dissection study

    Article • Cortex, July 2014, Elsevier

    Dr Christopher M Morris

  68. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease

    Article • Acta Neuropathologica, May 2014, Springer Science + Business Media

    Dr Christopher M Morris

  69. White matter connections of the supplementary motor area in humans

    Article • Journal of Neurology Neurosurgery & Psychiatry, April 2014, BMJ

    Dr Christopher M Morris

  70. Mitochondrial Abnormality Associates with Type-Specific Neuronal Loss and Cell Morphology Changes in the Pedunculopontine Nucleus in Parkinson Disease

    Article • American Journal Of Pathology, December 2013, Elsevier

    Dr Christopher M Morris

  71. Variation in tau isoform expression in different brain regions and disease states

    Article • Neurobiology of Aging, July 2013, Elsevier

    Dr Christopher M Morris

  72. A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

    Article • JAMA Neurology, June 2013, American Medical Association (AMA)

    Dr Christopher M Morris

  73. Neuroferritinopathy

    Article • January 2013, Elsevier

    Dr Christopher M Morris

  74. Sex differences in effects of low level domoic acid exposure

    Article • NeuroToxicology, January 2013, Elsevier

    Dr Christopher M Morris

  75. British Journal of Neurosurgery

    Article • Journal of Neurosurgery, December 2012, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Christopher M Morris, Mr Patrick Mitchell

  76. Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease

    Article • Journal of Neurochemistry, August 2012, Wiley

    Dr Christopher M Morris

  77. Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline

    Article • Redox Report, May 2012, Taylor & Francis

    Dr Christopher M Morris

  78. FUS and TDP43 genetic variability in FTD and CBS

    Article • Neurobiology of Aging, May 2012, Elsevier

    Dr Christopher M Morris

  79. Relationship Between Mitochondria and α-Synuclein

    Article • Archives of Neurology, March 2012, American Medical Association (AMA)

    Dr Christopher M Morris

  80. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project

    Article • Neurobiology of Aging, January 2012, Elsevier

    Dr Christopher M Morris

  81. Synaptic Protein Alterations in Parkinson’s Disease

    Article • Molecular Neurobiology, December 2011, Springer Science + Business Media

    Dr Christopher M Morris

  82. Cellular pathology within the anterior cingulate cortex of patients with late-life depression: A morphometric study

    Article • Psychiatry Research Neuroimaging, November 2011, Elsevier

    Dr Christopher M Morris

  83. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Article • Nature Genetics, June 2011, Springer Science + Business Media

    Prof. Herbert Budka, Dr Christopher M Morris, Professor Irene Litvan

  84. Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

    Article • Acta Neuropathologica, May 2011, Springer Science + Business Media

    Dr Christopher M Morris

  85. Any old iron?

    Article • Brain, April 2011, Oxford University Press (OUP)

    Dr Christopher M Morris

  86. NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors

    Article • Neurobiology of Aging, March 2011, Elsevier

    Dr Christopher M Morris

  87. Morphometric Analysis of Neuronal and Glial Cell Pathology in the Caudate Nucleus in Late-Life Depression

    Article • American Journal of Geriatric Psychiatry, February 2011, Elsevier

    Dr Christopher M Morris

  88. Examination of glucose transporter-1, transforming growth factor-β and neuroglobin immunoreactivity in the orbitofrontal cortex in late-life depression

    Article • Psychiatry and Clinical Neurosciences, January 2011, Wiley

    Dr Christopher M Morris

  89. Mitochondrial Dysfunction in Parkinson's Disease

    Article • Parkinson s Disease, January 2011, Hindawi Publishing Corporation

    Dr Christopher M Morris

  90. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions

    Article • Molecular Brain, January 2011, Springer Science + Business Media

    Dr Christopher M Morris

  91. The immunhistochemical examination of GABAergic interneuron markers in the dorsolateral prefrontal cortex of patients with late-life depression

    Article • International Psychogeriatrics, November 2010, Cambridge University Press

    Dr Christopher M Morris

  92. A morphometric examination of neuronal and glial cell pathology in the orbitofrontal cortex in late-life depression

    Article • International Psychogeriatrics, June 2010, Cambridge University Press

    Dr Christopher M Morris

  93. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

    Article • International Journal of Alzheimer s Disease, January 2010, Hindawi Publishing Corporation

    Dr Christopher M Morris

  94. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene

    Article • Annals of Neurology, December 2009, Wiley

    Dr Christopher M Morris

  95. The low abundance of clonally expanded mitochondrial DNA point mutations in aged substantia nigra neurons

    Article • Aging Cell, August 2009, Wiley

    Dr Christopher M Morris

  96. Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression

    Article • The British Journal of Psychiatry, August 2009, Royal College of Psychiatrists

    Dr Christopher M Morris

  97. BuChE-K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline

    Article • Movement Disorders, November 2008, Wiley

    Dr Christopher M Morris

  98. Nature of Mitochondrial DNA Deletions in Substantia Nigra Neurons

    Article • The American Journal of Human Genetics, January 2008, Elsevier

    Dr Christopher M Morris

  99. Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice

    Article • Neurochemical Research, December 2007, Springer Science + Business Media

    Dr Christopher M Morris

  100. Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease

    Article • Proceedings of the National Academy of Sciences, May 2007, Proceedings of the National Academy of Sciences

    Dr Christopher M Morris

  101. Individual dopaminergic neurons show raised iron levels in Parkinson disease

    Article • Neurology, May 2007, Wolters Kluwer Health

    Dr Christopher M Morris

  102. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts

    Article • Neurobiology of Disease, March 2007, Elsevier

    Dr Christopher M Morris

  103. Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL

    Article • Brain, February 2007, Oxford University Press (OUP)

    Dr Christopher M Morris

  104. Soluble cell adhesion molecules in late-life depression

    Article • International Psychogeriatrics, January 2007, Cambridge University Press

    Dr Christopher M Morris

  105. Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, January 2007, Elsevier

    Dr Christopher M Morris

  106. Apolipoprotein  3 allele is associated with persistent hepatitis C virus infection

    Article • Gut, May 2006, BMJ

    Dr Christopher M Morris

  107. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

    Article • Nature Genetics, April 2006, Springer Science + Business Media

    Dr Christopher M Morris

  108. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia

    Article • Neuropathology and Applied Neurobiology, April 2006, Wiley

    Dr Christopher M Morris

  109. Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?

    Article • Human Genetics, January 2006, Springer Science + Business Media

    Dr Christopher M Morris

  110. A Scan of Chromosome 10 Identifies a Novel Locus Showing Strong Association with Late-Onset Alzheimer Disease

    Article • The American Journal of Human Genetics, January 2006, Elsevier

    Dr Christopher M Morris

  111. Genetic Variability in CHMP2B and Frontotemporal Dementia

    Article • Neurodegenerative Diseases, January 2006, Karger Publishers

    Dr Christopher M Morris

  112. Looking for biogenic magnetite in brain ferritin using NMR relaxometry

    Article • NMR in Biomedicine, November 2005, Wiley

    Dr Christopher M Morris

  113. Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling

    Article • PROTEOMICS, October 2005, Wiley

    Dr Christopher M Morris

  114. Impact of Hypertension and Apolipoprotein E4 on Poststroke Cognition in Subjects >75 Years of Age

    Article • Stroke, September 2005, Wolters Kluwer Health

    Dr Christopher M Morris

  115. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease

    Article • Human Molecular Genetics, July 2005, Oxford University Press (OUP)

    Dr Christopher M Morris

  116. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, July 2005, Wiley

    Dr Christopher M Morris

  117. Angiotensin converting enzyme insertion/deletion polymorphisms in vasovagal syncope

    Article • EP Europace, July 2005, European Society of Cardiology

    Dr Christopher M Morris

  118. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

    Article • Journal of Medical Genetics, June 2005, BMJ

    Dr Christopher M Morris

  119. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation

    Article • Journal of Neurology Neurosurgery & Psychiatry, May 2005, BMJ

    Dr Christopher M Morris

  120. Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis

    Article • Neurogenetics, March 2005, Springer Science + Business Media

    Dr Janine Kirby, Dr Christopher M Morris

  121. Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease

    Article • Annals of Neurology, January 2005, Wiley

    Dr Christopher M Morris

  122. APOA1 polymorphism influences risk for early-onset nonfamiliar AD

    Article • Annals of Neurology, January 2005, Wiley

    Dr Christopher M Morris

  123. Familial neurocardiogenic (vasovagal) syncope

    Article • American Journal of Medical Genetics Part A, January 2005, Wiley

    Dr Christopher M Morris

  124. Increase in Interleukin-1β in Late-Life Depression

    Article • American Journal of Psychiatry, January 2005, American Psychiatric Association

    Dr Christopher M Morris

  125. The K Variant of the Butyrylcholinesterase Gene Is Associated with Reduced Phosphorylation of Tau in Dementia Patients

    Article • Dementia and Geriatric Cognitive Disorders, January 2005, Karger Publishers

    Dr Christopher M Morris

  126. Correction: no evidence of an association between the T16189C mtDNA variant and late onset dementia (Gibson et al)

    Article • Journal of Medical Genetics, December 2004, BMJ

    Dr Christopher M Morris

  127. High throughput approaches in neuroscience

    Article • International Journal of Developmental Neuroscience, November 2004, Elsevier

    Dr Christopher M Morris

  128. APOE  4 and cognitive decline in older stroke patients with early cognitive impairment

    Article • Neurology, October 2004, Wolters Kluwer Health

    Dr Christopher M Morris

  129. Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene

    Article • Neurogenetics, October 2004, Springer Science + Business Media

    Dr Christopher M Morris

  130. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies

    Article • Neurology, August 2004, Wolters Kluwer Health

    Dr Christopher M Morris

  131. Influence of the amyloid precursor protein locus on dementia in Down syndrome

    Article • Neurology, June 2004, Wolters Kluwer Health

    Dr Christopher M Morris

  132. Functional genomics and proteomics: application in neurosciences

    Article • Journal of Neurology Neurosurgery & Psychiatry, April 2004, BMJ

    Dr Christopher M Morris

  133. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease

    Article • Brain, January 2004, Oxford University Press (OUP)

    Dr Christopher M Morris

  134. Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease

    Article • Neuroscience Letters, December 2003, Elsevier

    Dr Christopher M Morris

  135. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA

    Article • Glia, August 2003, Wiley

    Dr Christopher M Morris

  136. Cognitive Decline in Down Syndrome—Reply

    Article • Archives of Neurology, July 2003, American Medical Association (AMA)

    Dr Christopher M Morris

  137. Regulation of attention and response to therapy in dementia by butyrylcholinesterase

    Article • Pharmacogenetics, April 2003, Wolters Kluwer Health

    Professor Keith A Wesnes, Dr Christopher M Morris

  138. Cholinesterase inhibitors in the treatment of dementia

    Article • International Journal of Geriatric Psychiatry, January 2003, Wiley

    Dr Christopher M Morris

  139. Dementia with Lewy bodies

    Article • Seminars in Clinical Neuropsychiatry, January 2003, Elsevier

    Dr Christopher M Morris

  140. Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration

    Article • Blood Cells Molecules and Diseases, November 2002, Elsevier

    Dr Christopher M Morris

  141. The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease

    Article • Neuroscience Letters, September 2002, Elsevier

    Dr Christopher M Morris

  142. Selective Nicotinic Receptor Consequences in APPSWE Transgenic Mice

    Article • Molecular and Cellular Neuroscience, June 2002, Elsevier

    Dr Christopher M Morris

  143. Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice

    Article • Journal of Neuroimmunology, May 2002, Elsevier

    Dr Christopher M Morris

  144. Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies

    Article • Dementia and Geriatric Cognitive Disorders, January 2002, Karger Publishers

    Dr Christopher M Morris

  145. Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans

    Article • Neuroscience Letters, January 2002, Elsevier

    Dr Christopher M Morris

  146. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

    Article • Nature Genetics, July 2001, Springer Science + Business Media

    Dr Christopher M Morris

  147. No pathogenic mutations in the synphilin-1 gene in Parkinson's disease

    Article • Neuroscience Letters, July 2001, Elsevier

    Dr Christopher M Morris

  148. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies

    Article • Neuroscience Letters, April 2001, Elsevier

    Dr Christopher M Morris

  149. Is apolipoprotein e4 associated with cognitive decline in depression?

    Article • International Journal of Geriatric Psychiatry, January 2001, Wiley

    Dr Christopher M Morris

  150. Parkinson's disease is not associated with the combined ?-synuclein/apolipoprotein E susceptibility genotype

    Article • Annals of Neurology, January 2001, Wiley

    Dr Christopher M Morris

  151. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease

    Article • International Journal of Geriatric Psychiatry, January 2001, Wiley

    Dr Christopher M Morris

  152. Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

    Article • Dementia and Geriatric Cognitive Disorders, December 2000, Karger Publishers

    Dr Christopher M Morris

  153. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease

    Article • Neuroscience Letters, September 2000, Elsevier

    Dr Christopher M Morris

  154. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies

    Article • Neurology, July 2000, Wolters Kluwer Health

    Dr Christopher M Morris

  155. Non-Alzheimer dementias

    Article • Current Opinion in Psychiatry, July 2000, Wolters Kluwer Health

    Dr Christopher M Morris

  156. Brain oestradiol and testosterone levels in Alzheimer's disease

    Article • Neuroscience Letters, May 2000, Elsevier

    Dr Christopher M Morris

  157. Distribution of Amyloid beta42 in Relation to the Cerebral Microvasculature in an Elderly Cohort with Alzheimer's Disease

    Article • Annals of the New York Academy of Sciences, April 2000, Wiley

    Dr Christopher M Morris

  158. Hereditary Vascular Dementia Linked to Notch 3 Mutations: CADASIL in British Families

    Article • Annals of the New York Academy of Sciences, April 2000, Wiley

    Dr Christopher M Morris

  159. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies

    Article • Neuroreport, February 2000, Wolters Kluwer Health

    Dr Christopher M Morris

  160. Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03

    Article • Neuroscience Letters, November 1999, Elsevier

    Dr Christopher M Morris

  161. Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased A 42 Secretion

    Article • Human Molecular Genetics, August 1999, Oxford University Press (OUP)

    Dr Christopher M Morris

  162. Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias

    Article • Archives of Neurology, August 1999, American Medical Association (AMA)

    Dr Christopher M Morris

  163. α2-Macroglobulin polymorphisms in Alzheimerʼs disease and dementia with Lewy bodies

    Article • Neuroreport, May 1999, Wolters Kluwer Health

    Dr Christopher M Morris

  164. Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease

    Article • Neuroscience Letters, March 1999, Elsevier

    Dr Christopher M Morris

  165. Diagnosis of Mitochondrial Disease: Assessment of Mitochondrial DNA Heteroplasmy in Blood

    Article • Biochemical and Biophysical Research Communications, October 1998, Elsevier

    Dr Christopher M Morris

  166. LRP gene and late-onset Alzheimer's disease

    Article • The Lancet, July 1998, Elsevier

    Dr Christopher M Morris

  167. Butyrylcholinesterase K: an association with dementia with Lewy bodies

    Article • The Lancet, June 1998, Elsevier

    Dr Christopher M Morris

  168. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use

    Article • Neuroscience, June 1998, Elsevier

    Dr Christopher M Morris

  169. Neuroblastoma and Alzheimer’s Disease Brain Cells Contain Aromatase Activity

    Article • Steroids, May 1998, Elsevier

    Dr Christopher M Morris

  170. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease

    Article • Human Molecular Genetics, May 1998, Oxford University Press (OUP)

    Dr Christopher M Morris

  171. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population

    Article • Pharmacogenetics, April 1998, Wolters Kluwer Health

    Dr Christopher M Morris

  172. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies Distinctions between diseases

    Article • Neurology, February 1998, Wolters Kluwer Health

    Dr Christopher M Morris

  173. D2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele

    Article • Pharmacogenetics, December 1997, Wolters Kluwer Health

    Dr Christopher M Morris

  174. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies

    Article • Neuroreport, November 1997, Wolters Kluwer Health

    Dr Christopher M Morris

  175. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease

    Article • Neuroscience Letters, September 1997, Elsevier

    Dr Christopher M Morris

  176. Presenilin polymorphisms in Alzheimer's disease

    Article • The Lancet, September 1997, Elsevier

    Dr Christopher M Morris

  177. HLA-DR antigens associated with major genetic risk for late-onset Alzheimerʼs disease

    Article • Neuroreport, April 1997, Wolters Kluwer Health

    Dr Christopher M Morris

  178. Effect of aluminium on expression and processing of amyloid precursor protein

    Article • Journal of Neuroscience Research, November 1996, Wiley

    Dr Christopher M Morris

  179. Apolipoprotein E genotyping in Alzheimer's disease

    Article • The Lancet, June 1996, Elsevier

    Dr Christopher M Morris

  180. Apolipoprotein E Genotype and Alzheimer's Disease in an Elderly Norwegian Cohort

    Article • Neurodegeneration, March 1996, Elsevier

    Dr Christopher M Morris

  181. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians

    Article • Neuroscience Letters, December 1995, Elsevier

    Dr Christopher M Morris

  182. Effects of Apolipoprotein E Genotype on Cortical Neuropathology in Senile Dementia of the Lewy Body and Alzheimer's Disease

    Article • Neurodegeneration, December 1995, Elsevier

    Dr Christopher M Morris

  183. The role of the cholinergic system in the development of the human cerebellum

    Article • Developmental Brain Research, December 1995, Elsevier

    Dr Christopher M Morris

  184. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology

    Article • Neuroscience, January 1995, Elsevier

    Dr Christopher M Morris

  185. Distribution of Nicotinic Receptors in the Human Hippocampus and Thalamus

    Article • European Journal of Neuroscience, October 1994, Wiley

    Dr Christopher M Morris

  186. Transferrin receptors in the Parkinsonian midbrain

    Article • Neuropathology and Applied Neurobiology, October 1994, Wiley

    Dr Christopher M Morris

  187. Transferrin receptors in the normal human hippocampus and in Alzheimer's disease

    Article • Neuropathology and Applied Neurobiology, October 1994, Wiley

    Dr Christopher M Morris

  188. Protective effect of apoE ∈2 in Alzheimer's disease

    Article • The Lancet, August 1994, Elsevier

    Dr Christopher M Morris

  189. Distribution of neuronal nicotinic receptor subunits in human brain

    Article • Neurochemistry International, July 1994, Elsevier

    Dr Christopher M Morris

  190. Apolipoprotein E genes in Lewy body and Parkinson's disease

    Article • The Lancet, June 1994, Elsevier

    Dr Christopher M Morris

  191. Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus

    Article • Hippocampus, July 1993, Wiley

    Dr Christopher M Morris

  192. Iron uptake in the brain of the myelin-deficient rat

    Article • Neuroscience Letters, May 1993, Elsevier

    Dr Christopher M Morris

  193. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia

    Article • Alzheimer Disease & Associated Disorders, January 1993, Wolters Kluwer Health

    Dr Christopher M Morris

  194. Evidence for the localization of haemopexin immunoreactivity in neurones in the human brain

    Article • Neuroscience Letters, January 1993, Elsevier

    Dr Christopher M Morris

  195. Hippocampal p75 Nerve Growth Factor Receptor Immunoreactivity in Development, Normal Aging and Senescence

    Article • Cells Tissues Organs, January 1993, Karger Publishers

    Dr Christopher M Morris

  196. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

    Article • Biochemical Journal, October 1992, Portland Press Ltd.

    Dr Christopher M Morris

  197. Distribution of transferrin receptors in relation to cytochrome oxidase activity in the human spinal cord, lower brainstem and cerebellum

    Article • Journal of the Neurological Sciences, September 1992, Elsevier

    Dr Christopher M Morris

  198. Brain iron homeostasis

    Article • Journal of Inorganic Biochemistry, August 1992, Elsevier

    Dr Christopher M Morris

  199. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease

    Article • Neuroscience Letters, August 1992, Elsevier

    Dr Christopher M Morris

  200. Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain

    Article • Journal of Neurochemistry, July 1992, Wiley

    Dr Christopher M Morris

  201. Immunocytochemical Localisation of Transferrin in the Human Brain

    Article • Cells Tissues Organs, January 1992, Karger Publishers

    Dr Christopher M Morris

  202. Nerve Growth Factor Receptor-like Immunoreactivity in the Human Spinal Cord

    Article • Cells Tissues Organs, January 1992, Karger Publishers

    Dr Christopher M Morris

  203. The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)

    Article • Biology of the Cell, January 1992, Wiley

    Dr Christopher M Morris

  204. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases

    Article • Journal of the Neurological Sciences, November 1991, Elsevier

    Dr Christopher M Morris

  205. Transferrin-gallium binding in Alzheimer's disease

    Article • The Lancet, November 1991, Elsevier

    Dr Christopher M Morris

  206. Laterality and 5HT2 receptors in human brain

    Article • Psychiatry Research, February 1991, Elsevier

    Dr Christopher M Morris

  207. Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus

    Article • Neuroscience Letters, January 1991, Elsevier

    Dr Christopher M Morris

  208. Brain transferrin receptors and the distribution of cytochrome oxidase

    Article • Biochemical Society Transactions, August 1990, Portland Press Ltd.

    Dr Christopher M Morris

  209. Gallium-67 as a Potential Marker for Aluminium Transport in Rat Brain: Implications for Alzheimer's Disease

    Article • Journal of Neurochemistry, July 1990, Wiley

    Dr Christopher M Morris

  210. Gallium-transferrin binding in Alzheimer disease

    Article • The Lancet, June 1990, Elsevier

    Dr Christopher M Morris

  211. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients

    Article • Journal of the Neurological Sciences, December 1989, Elsevier

    Dr Christopher M Morris

  212. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients

    Article • Biochemical Society Transactions, August 1989, Portland Press Ltd.

    Dr Christopher M Morris

  213. Interaction between metal ions and neuroleptics

    Article • Biochemical Society Transactions, February 1989, Portland Press Ltd.

    Dr Christopher M Morris